ReviewTravel medicine and infectious disease
A review on insights and lessons from COVID-19 to the prevent of monkeypox pandemic.
Review in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database.Frontiers in public health · 2023Pooled it
- Exploring Therapeutic Strategies against Monkeypox Virus Through Network Pharmacology and Bioinformatics Analysis.Current medicinal chemistry · 2026Article
- Monkeypox virus and type 1 diabetes: a molecular insight into inflammatory signaling and β-cell autoimmunity.Virology journal · 2025Review
- 3D-EDiffMG: 3D equivariant diffusion-driven molecular generation to accelerate drug discovery.Journal of pharmaceutical analysis · 2025Article
- Review
- Clade Ib: a new emerging threat in the Mpox outbreak.Frontiers in pharmacology · 2024Review
- Article
- Knowledge, attitude, and perception of Pakistani populations toward monkeypox: a cross-section study.Frontiers in cellular and infection microbiology · 2024Article
- Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions.Infectious medicine · 2023Review
- Review
- Clinical Predictors of Monkeypox Diagnosis: A Case-Control Study in a Nonendemic Region during the 2022 Outbreak.Microorganisms · 2023Article
- Progress and prospects on vaccine development against monkeypox infection.Microbial pathogenesis · 2023Review
- Review
- Application of Artificial Intelligence Techniques for Monkeypox: A Systematic Review.Diagnostics (Basel, Switzerland) · 2023Review
- Mpox, Caused by the MPXV of the Clade IIb Lineage, Goes Global.Tropical medicine and infectious disease · 2023Article
- Socio-demographic determinants of Monkeypox virus preventive behavior: A cross-sectional study in Pakistan.PloS one · 2023Article
- The Emergence of Mpox: Epidemiology and Current Therapeutic Options.Current pharmacology reports · 2023Review
- Global transmission of monkeypox virus-a potential threat under the COVID-19 pandemic.Frontiers in immunology · 2023Review
- In silico design and immunoinformatics analysis of a universal multi-epitope vaccine against monkeypox virus.PloS one · 2023Article
- Prevention, Risk Exposure, and Knowledge of Monkeypox in Occupational Settings: A Scoping Review.Tropical medicine and infectious disease · 2022Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Re-emerging of monkeypox virus (MPXV), a neglected viral zoonotic disease, is a potential global threat. In the current COVID-19 pandemic status, the increasing reporting of positive cases of human MPXV in most countries of the world is a major reason for concern. This paper aims to describe the insights and lessons from COVID-19 pandemic in preventing the impending danger MPXV. In order to prevent further outbreak of disease, identify and control of MPXV transmission routes is necessary. Public health authorities should be vigilant and applied of effective strategies to mitigate the potential spread of MPXV. To address research gaps related to MPX outbreaks, national, regional, and international collaborations are required in time. Finally, the lessons and insights put forward point to the fact that, like the COVID-19 pandemic, people's health by and large depends on the decisions of government officials and people must continue to adhere to health principles. Hence, governments and policymakers must take appropriate precautionary measures to prevent similar crises like COVID-19 in the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.